Our Business Model

Nanotherapeutics is a specialty pharmaceutical company with an emphasis on the preclinical and early clinical development of novel or modified dosage forms.

The core competency of Nanotherapeutics is development of novel delivery systems and the GMP manufacture of resulting formulations. We have considerable expertise in the application of our proprietary delivery technologies to a range of compounds and materials for potential therapeutic benefit. Our strategy going forward is designed to exploit these capabilities both in collaboration with established companies and for the creation of the Company’s own internal pipeline.

• We work with established companies to develop new delivery modes.
  Enhance dosage forms for new and existing drugs and compounds.
  
• We develop our internal drug candidates through to phase I/II.
  License these opportunities to Pharmaceutical partners.
  
  

We intend to retain manufacturing rights for dosage forms for our partners. We believe many aspects of our technologies are not readily reproduced, and they impart unique properties to drugs that can not be matched by any other currently available process.

We invite conversations with interested parties to discuss their drug delivery needs and our capabilities to meet those needs.